Ensign Peak Advisors
MYOK

Ensign Peak Advisors’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Ensign Peak Advisors’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-32,715
Closed -$4.46M – 1903
2020
Q3 		$4.46M Sell
32,715
-19,303
-37% -$2.05M 0.01% 662
2020
Q2 		$5.03M Buy
52,018
+10,548
+25% +$880K 0.01% 607
2020
Q1 		$1.94M Sell
41,470
-1,403
-3% -$89.9K 0.01% 843
2019
Q4 		$3.13M Buy
+42,873
New +$2.6M 0.01% 828

Ensign Peak Advisors's MYOK Position: Q4 2020 in Review

Ensign Peak Advisors sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 32,715 shares — an estimated $4.46M sold.

Ensign Peak Advisors first reported a position in MYOK in Q4 2019 and held it in 4 quarters. The position peaked at $5.03M in Q2 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Ensign Peak Advisors reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Ensign Peak Advisors sold 32,715 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $4.46M.
  • Ensign Peak Advisors first reported a position in MyoKardia, Inc. Common Stock in Q4 2019 and held it in 4 quarters.
  • Ensign Peak Advisors's MyoKardia, Inc. Common Stock position peaked at $5.03M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Ensign Peak Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.